Cannabis and Opioid Use Disorder, Study 2

Summary

This inpatient study enrolls healthy individuals who have opioid use disorder. Participants live at the University of Kentucky Hospital for approx. 6 weeks. During this time, we will examine how repeated doses of oral cannabis and acute doses of oral and inhaled cannabis 1) modify the intensity and time course of opioid withdrawal, 2) modify the effects of intranasal opioid administration and 3) impact the safety of opioid administration.

Timeline

Start

2026-07-30

Primary completion

2029-07-30

Completion

2030-01-30

Drugs

Indications